Progressive Multiple Sclerosis
📧 Sign up to get email alerts when something new happens for Progressive Multiple Sclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-03-30Clinical Trial Update: Disease Modifying Therapies Withdrawal in Inactive Secondary Progressive Multiple Sclerosis Patients Older Than 50 Years (STOP-I-SEP) [Phase 3]
Phase 3 clinical trial evaluating withdrawal of disease-modifying therapies in inactive secondary progressive multiple sclerosis patients ov…
-
CLINICAL_TRIALS withdrawal · 2025-12-04Clinical Trial Update: Managed Access Program (MAP) for Patients Diagnosed With Secondary Progressive Multiple Sclerosis With Active Disease
The clinical trial update confirms that the Novartis-sponsored Managed Access Program for patients with secondary progressive multiple scler…
-
CLINICAL_TRIALS withdrawal · 2013-09-16Clinical Trial Update: Dose Escalation Study to Evaluate the Penetration and Pharmacodynamic Effects of Baminercept in the Cerebrospinal Fluid (CSF)and Safety in Subjects With Secondary Progressive Multiple Sclerosis (SPMS) [Phase 1, Phase 2]
Biogen has withdrawn a dose-escalation Phase 1/2 trial of Baminercept in secondary progressive multiple sclerosis.